Result of AGM and Voting Results

EKF Diagnostics Holdings PLC
17 May 2023
 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Result of AGM and Voting Results

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that at it's Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

 

The voting results of the AGM were as follows:

 

 

For

Against

Withheld

Resolution

Votes

%

Votes

%

Votes

1

299,140,487

99.99%

                25,430

0.01%

               12,000

2

299,164,209

100.00%

                  1,708

0.00%

               12,000

3

296,684,235

99.17%

           2,481,682

0.83%

               12,000

4

277,821,196

92.87%

         21,344,721

7.13%

               12,000

5

299,127,062

99.99%

                38,855

0.01%

               12,000

6

298,964,519

99.95%

              158,855

0.05%

               54,543

7

283,417,147

94.75%

         15,704,227

5.25%

               56,543

8

239,170,516

93.84%

         15,704,227

6.16%

        44,303,174

9

242,369,025

99.97%

                72,261

0.03%

        56,736,631

10

290,020,135

96.94%

           9,145,782

3.06%

               12,000

 

 

 

 

EKF Diagnostics Holdings plc

www.ekfdiagnostics.com

Julian Baines, Executive Chair / Marc Davies, CFO

 Tel: +44 (0)29 2071 0570



Singer Capital Markets (Nominated Adviser & Broker)

Tel: +44 (0)20 7496 3000

Aubrey Powell / George Tzimas / Oliver Platts




Walbrook PR Limited

Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com

Paul McManus / Lianne Applegarth

Mob: +44 (0)7980 541 893 / +44 (0)7584 391 303

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

 

EKF is an AIM-listed global diagnostics business focussed on:

 

·    Point-of-Care analysers in the key areas of Hematology and Diabetes, as well as Central Laboratory products including clinical chemistry reagents, analysers and centrifuges

 

·    Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic food and industrial applications, as well as other higher value Contract Manufacturing services

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100